BOIRON SA (BOI.PA) Stock Fundamental Analysis
Europe - EPA:BOI - FR0000061129 - Common Stock
26 EUR
+1.5 (+6.12%)
We assign a fundamental rating of 5 out of 10 to BOI. BOI was compared to 49 industry peers in the Pharmaceuticals industry. While BOI has a great health rating, there are worries on its profitability. BOI has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
BOI had positive earnings in the past year.
BOI had a positive operating cash flow in the past year.
BOI had positive earnings in each of the past 5 years.
Each year in the past 5 years BOI had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.97%, BOI is doing worse than 61.22% of the companies in the same industry.
The Return On Equity of BOI (3.00%) is worse than 61.22% of its industry peers.
With a Return On Invested Capital value of 2.54%, BOI is not doing good in the industry: 61.22% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for BOI is significantly below the industry average of 15.25%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.97% | ||
| ROE | 3% | ||
| ROIC | 2.54% |
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
1.3 Margins
BOI has a Profit Margin (2.33%) which is in line with its industry peers.
BOI's Profit Margin has declined in the last couple of years.
BOI has a Operating Margin of 3.23%. This is comparable to the rest of the industry: BOI outperforms 40.82% of its industry peers.
BOI's Operating Margin has declined in the last couple of years.
BOI has a Gross Margin of 73.58%. This is in the better half of the industry: BOI outperforms 63.27% of its industry peers.
BOI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.23% | ||
| PM (TTM) | 2.33% | ||
| GM | 73.58% |
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BOI is destroying value.
BOI has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for BOI has been reduced compared to 5 years ago.
BOI has a worse debt/assets ratio than last year.
2.2 Solvency
BOI has an Altman-Z score of 3.33. This indicates that BOI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BOI (3.33) is comparable to the rest of the industry.
BOI has a debt to FCF ratio of 0.63. This is a very positive value and a sign of high solvency as it would only need 0.63 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.63, BOI belongs to the best of the industry, outperforming 93.88% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that BOI is not too dependend on debt financing.
BOI's Debt to Equity ratio of 0.03 is amongst the best of the industry. BOI outperforms 83.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.63 | ||
| Altman-Z | 3.33 |
ROIC/WACC0.33
WACC7.81%
2.3 Liquidity
A Current Ratio of 2.51 indicates that BOI has no problem at all paying its short term obligations.
BOI's Current ratio of 2.51 is amongst the best of the industry. BOI outperforms 81.63% of its industry peers.
BOI has a Quick Ratio of 1.61. This is a normal value and indicates that BOI is financially healthy and should not expect problems in meeting its short term obligations.
BOI has a better Quick ratio (1.61) than 81.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.61 |
3. Growth
3.1 Past
BOI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.36%.
Measured over the past years, BOI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.40% on average per year.
Looking at the last year, BOI shows a decrease in Revenue. The Revenue has decreased by -1.15% in the last year.
The Revenue has been decreasing by -2.63% on average over the past years.
EPS 1Y (TTM)-68.36%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%-60.69%
Revenue 1Y (TTM)-1.15%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%2.31%
3.2 Future
Based on estimates for the next years, BOI will show a small growth in Earnings Per Share. The EPS will grow by 2.73% on average per year.
Based on estimates for the next years, BOI will show a small growth in Revenue. The Revenue will grow by 5.54% on average per year.
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
BOI is valuated quite expensively with a Price/Earnings ratio of 40.00.
The rest of the industry has a similar Price/Earnings ratio as BOI.
BOI's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.41.
Based on the Price/Forward Earnings ratio of 11.24, the valuation of BOI can be described as reasonable.
Based on the Price/Forward Earnings ratio, BOI is valued a bit cheaper than the industry average as 73.47% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, BOI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40 | ||
| Fwd PE | 11.24 |
4.2 Price Multiples
BOI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BOI is cheaper than 89.80% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BOI indicates a somewhat cheap valuation: BOI is cheaper than 65.31% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.33 | ||
| EV/EBITDA | 6.29 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)7.23
PEG (5Y)N/A
EPS Next 2Y2.73%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.11%, BOI is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.04, BOI pays a better dividend. On top of this BOI pays more dividend than 89.80% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, BOI pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.11% |
5.2 History
The dividend of BOI decreases each year by -1.41%.
Dividend Growth(5Y)-1.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
206.77% of the earnings are spent on dividend by BOI. This is not a sustainable payout ratio.
DP206.77%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPA:BOI (9/19/2025, 11:36:11 AM)
26
+1.5 (+6.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners5.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap456.30M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.11% |
Yearly Dividend1.35
Dividend Growth(5Y)-1.41%
DP206.77%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40 | ||
| Fwd PE | 11.24 | ||
| P/S | 0.94 | ||
| P/FCF | 19.33 | ||
| P/OCF | 11.54 | ||
| P/B | 1.21 | ||
| P/tB | 1.76 | ||
| EV/EBITDA | 6.29 |
EPS(TTM)0.65
EY2.5%
EPS(NY)2.31
Fwd EY8.9%
FCF(TTM)1.34
FCFY5.17%
OCF(TTM)2.25
OCFY8.66%
SpS27.78
BVpS21.55
TBVpS14.77
PEG (NY)7.23
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.97% | ||
| ROE | 3% | ||
| ROCE | 3.39% | ||
| ROIC | 2.54% | ||
| ROICexc | 3.01% | ||
| ROICexgc | 4.32% | ||
| OM | 3.23% | ||
| PM (TTM) | 2.33% | ||
| GM | 73.58% | ||
| FCFM | 4.84% |
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
ROICexc(3y)8.01%
ROICexc(5y)8.34%
ROICexgc(3y)11.86%
ROICexgc(5y)12.41%
ROCE(3y)7.49%
ROCE(5y)7.29%
ROICexcg growth 3Y-33.41%
ROICexcg growth 5Y-24.37%
ROICexc growth 3Y-32.4%
ROICexc growth 5Y-24.82%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.63 | ||
| Debt/EBITDA | 0.18 | ||
| Cap/Depr | 37.59% | ||
| Cap/Sales | 3.27% | ||
| Interest Coverage | 14.49 | ||
| Cash Conversion | 68.03% | ||
| Profit Quality | 208.21% | ||
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.61 | ||
| Altman-Z | 3.33 |
F-Score7
WACC7.81%
ROIC/WACC0.33
Cap/Depr(3y)71.98%
Cap/Depr(5y)71.7%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.78%
Profit Quality(3y)124.88%
Profit Quality(5y)120.26%
High Growth Momentum
Growth
EPS 1Y (TTM)-68.36%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%-60.69%
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.15%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%2.31%
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
EBIT growth 1Y-62.79%
EBIT growth 3Y-30.48%
EBIT growth 5Y-25.59%
EBIT Next Year86.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.06%
FCF growth 3Y22.31%
FCF growth 5Y12.1%
OCF growth 1Y-13.1%
OCF growth 3Y5.87%
OCF growth 5Y-4.91%